CFR 21 Part 820 (QSR) Internal Auditing Services
Our CFR 21 Part 820 Internal Auditing services support medical device manufacturers in ensuring compliance with FDA Quality System Regulation (QSR) requirements. Patient Guard provides independent, expert audits to help you identify gaps, reduce regulatory risk, and maintain inspection readiness.
CFR 21 Part 820 (QSR) Internal Auditing Services
Medical device manufacturers distributing products in the United States must comply with the FDA’s Quality System Regulation (21 CFR Part 820).
Internal audits are a critical component of maintaining compliance, ensuring that your Quality Management System (QMS) is effectively implemented and aligned with FDA requirements.
Patient Guard provides professional CFR 21 Part 820 internal auditing services, delivering an independent and objective review of your QMS against FDA expectations.
We help organisations prepare for FDA inspections, identify compliance gaps, and strengthen quality system processes.
Whether preparing for an FDA inspection or maintaining ongoing compliance, we ensure your QMS is audit-ready and aligned with regulatory requirements.
Why Choose Patient Guard for QSR Internal Auditing?
Established regulatory consultancy since 2017
We have extensive experience supporting medical device manufacturers with global regulatory compliance.
Trusted by 500+ companies
We support start-ups, SMEs and global manufacturers across medical device sectors.
FDA-focused audit expertise
Our audits are aligned with FDA expectations and inspection practices.
Transparent pricing
Clear project-based or fixed pricing with no hidden costs.
Clear and actionable reporting
We provide detailed audit reports with practical, compliance-focused recommendations.
Patient Guard have been a great support service to Cormed, providing help and advice promptly whenever requested. They have become a virtual department within Cormed enabling us to keep up to date and comply with the regulatory requirements whilst ensuring our QMS works for us at the same time.”
Tracey Slater, Cormed
What Our CFR 21 Part 820 Internal Auditing Service Includes
Full QMS audit against 21 CFR Part 820
We conduct comprehensive audits of your Quality Management System against FDA QSR requirements.
Process and system evaluation
We assess core quality system processes including design controls, CAPA, and production controls.
Documentation review
We review procedures, records, and quality documentation to ensure compliance with FDA requirements.
Identification of nonconformities
We identify compliance gaps, observations, and areas for improvement.
Audit reporting and recommendations
We provide detailed audit reports with clear findings and corrective action guidance.
Inspection readiness support
We help prepare your organisation for FDA inspections and audits.
Who Requires CFR 21 Part 820 Internal Auditing?
- Medical device manufacturers selling in the United States
- Organisations preparing for FDA inspections
- Companies maintaining FDA QSR compliance
- Start-ups entering the US medical device market
FDA QSR (21 CFR Part 820) Requirements
Under 21 CFR Part 820, manufacturers must establish and maintain a quality system that ensures products consistently meet regulatory and safety requirements.
Internal audits are expected to:
- Verify compliance with QSR requirements
- Ensure procedures are effectively implemented
- Identify quality system gaps
- Support corrective and preventive actions (CAPA)
- Maintain inspection readiness
Our Process
Audit planning
We define scope, schedule, and audit objectives.
Audit execution
We conduct the audit, including interviews, document review, and process assessment.
Reporting
We provide findings, identify non-conformities, and support corrective actions.
Areas we assess
We assess all key areas of your QMS, including:
- Design controls
- Corrective and Preventive Actions (CAPA)
- Document and record control
- Production and process controls
- Supplier management
- Complaint handling and vigilance
- Training and personnel competence
Cost of Service
CFR 21 Part 820 QSR Internal Auditing
From
Ensure ongoing compliance and Inspection readiness with expert CFR21 Part 820 quality Internal audits.
Audit Costs
- Small Size Organisation (<10 employees) 2 day audit £2,000
- Medium Size Organisation (10-50 employees) 3 day audit £3,000
- Large Size Organisation (>50 employees) 4 day audit £4,000
Time Lines
Planning
1-2 weeks
Audit
2-4 days depending on organisation size
Reporting
2-4 days depending on organisation size
Frequently Asked Questions (FAQs)
What is a CFR 21 Part 820 internal audit?
A CFR 21 Part 820 internal audit is a systematic review of a manufacturer’s Quality Management System to ensure compliance with FDA Quality System Regulation requirements.
Are internal audits required under FDA QSR?
While not explicitly labelled the same as ISO standards, internal audits are expected as part of maintaining an effective quality system and ensuring ongoing compliance.
Can internal audits be outsourced?
Yes, outsourcing internal audits ensures independence, objectivity, and access to experienced FDA regulatory experts.
How often should QSR audits be conducted?
Audits should be conducted at planned intervals, typically annually or more frequently depending on risk and organisational complexity.
How long does a QSR internal audit take?
The duration depends on the size and complexity of your QMS but typically ranges from 2–5 days.
Related Services
Click on the links below to discover more:
Recent Blog Posts

ISO 14971 Risk Management Implementation Guide
Medical devices exist to improve health outcomes, but every device carries potential risk. Managing those risks in a structured, documented, and defensible way is essential for regulatory approval and patient safety.

Clinical Evaluation Report: EU MDR Requirements
Clinical evidence is central to demonstrating the safety and performance of medical devices in the European Union.

Medical Device Labelling Requirements Explained
Medical device labelling is more than a packaging exercise. It is a regulatory requirement that communicates essential information about a device’s identity, safety, and intended use.

Medical Device Post-Market Surveillance Guide
Regulatory approval is not the end of scrutiny, it is the beginning of structured data collection.

ISO 13485:2016 Requirements & Implementation Guide
If you are implementing a medical device QMS, preparing for certification, or recovering from audit findings, understanding ISO 13485:2016 requirements is non-negotiable.

IVDR Transitional Provisions: 2026 Milestones
2026 represents a significant milestone for the amended IVDR transitional provisions framework.